Frontier Biotechnologies Inc. Class ASSE: 688221

"Frontier Biotechnologies Inc."Announcement on Return of Idle Raised Funds Temporarily Used to Supplement Working Capital

Sep 4, 2026 · Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange

Announcement on Return of Idle Raised Funds Temporarily Used to Supplement Working Capital

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Frontier Biotechnologies Inc. Class A

"Frontier Biotechnologies Inc."Announcement on Use of Temporarily Idle Raised Funds for Cash ManagementAug 31
"Frontier Biotechnologies Inc."Voluntary Disclosure Announcement on Obtaining Drug Registration Certificate for FB3002 Loxoprofen Sodium PatchesAug 21
"Frontier Biotechnologies Inc."Indicative Announcement on Change in Equity of Shareholders Holding More Than 5% of the Shares Reaching 1% and 5% ThresholdAug 13
"Frontier Biotechnologies Inc."Announcement on Returning Idle Raised Funds Used to Temporarily Supplement Current CapitalJul 11

All Frontier Biotechnologies Inc. Class A news releases